Legal & General Group
REGN icon

Legal & General Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$388M Sell
739,581
-7,452
-1% -$3.91M 0.1% 209
2025
Q1
$474M Sell
747,033
-30,444
-4% -$19.3M 0.13% 160
2024
Q4
$554M Sell
777,477
-7,617
-1% -$5.43M 0.15% 123
2024
Q3
$825M Buy
785,094
+1,301
+0.2% +$1.37M 0.22% 84
2024
Q2
$824M Sell
783,793
-35,489
-4% -$37.3M 0.23% 75
2024
Q1
$789M Sell
819,282
-7,406
-0.9% -$7.13M 0.23% 83
2023
Q4
$726M Buy
826,688
+6,480
+0.8% +$5.69M 0.23% 84
2023
Q3
$675M Sell
820,208
-26,921
-3% -$22.2M 0.24% 80
2023
Q2
$609M Sell
847,129
-1,998
-0.2% -$1.44M 0.2% 103
2023
Q1
$698M Buy
849,127
+17,758
+2% +$14.6M 0.25% 80
2022
Q4
$600M Sell
831,369
-41,616
-5% -$30M 0.23% 95
2022
Q3
$601M Sell
872,985
-10,302
-1% -$7.1M 0.23% 89
2022
Q2
$522M Buy
883,287
+75,391
+9% +$44.6M 0.18% 110
2022
Q1
$564M Buy
807,896
+57,387
+8% +$40.1M 0.17% 115
2021
Q4
$474M Sell
750,509
-15,609
-2% -$9.86M 0.14% 146
2021
Q3
$464M Buy
766,118
+21,066
+3% +$12.7M 0.15% 136
2021
Q2
$416M Buy
745,052
+36,408
+5% +$20.3M 0.14% 153
2021
Q1
$335M Sell
708,644
-14,582
-2% -$6.9M 0.12% 187
2020
Q4
$349M Buy
723,226
+39,979
+6% +$19.3M 0.14% 158
2020
Q3
$382M Sell
683,247
-9,181
-1% -$5.14M 0.17% 125
2020
Q2
$432M Buy
692,428
+157,929
+30% +$98.5M 0.21% 94
2020
Q1
$261M Buy
534,499
+12,205
+2% +$5.95M 0.15% 152
2019
Q4
$196M Buy
522,294
+21,108
+4% +$7.93M 0.09% 243
2019
Q3
$139M Buy
501,186
+7,319
+1% +$2.03M 0.07% 300
2019
Q2
$155M Buy
493,867
+15,410
+3% +$4.82M 0.08% 276
2019
Q1
$196M Buy
478,457
+93,957
+24% +$38.6M 0.11% 212
2018
Q4
$144M Buy
384,500
+24,498
+7% +$9.15M 0.11% 215
2018
Q3
$145M Buy
360,002
+8,792
+3% +$3.55M 0.1% 222
2018
Q2
$121M Sell
351,210
-13,767
-4% -$4.75M 0.09% 245
2018
Q1
$126M Buy
364,977
+3,437
+1% +$1.18M 0.1% 244
2017
Q4
$136M Sell
361,540
-9,570
-3% -$3.6M 0.1% 239
2017
Q3
$166M Buy
371,110
+2,729
+0.7% +$1.22M 0.12% 195
2017
Q2
$181M Buy
368,381
+8,060
+2% +$3.96M 0.15% 174
2017
Q1
$140M Buy
360,321
+16,117
+5% +$6.25M 0.12% 204
2016
Q4
$126M Buy
344,204
+2,207
+0.6% +$810K 0.12% 203
2016
Q3
$137M Buy
341,997
+4,324
+1% +$1.74M 0.14% 173
2016
Q2
$118M Buy
337,673
+1,590
+0.5% +$555K 0.12% 195
2016
Q1
$121M Sell
336,083
-5,709
-2% -$2.06M 0.13% 176
2015
Q4
$186M Buy
341,792
+25,766
+8% +$14M 0.21% 108
2015
Q3
$147M Buy
316,026
+10,886
+4% +$5.06M 0.18% 136
2015
Q2
$156M Buy
305,140
+2,062
+0.7% +$1.05M 0.18% 132
2015
Q1
$137M Sell
303,078
-55
-0% -$24.8K 0.16% 146
2014
Q4
$124M Sell
303,133
-2,805
-0.9% -$1.15M 0.15% 167
2014
Q3
$110M Sell
305,938
-15,504
-5% -$5.59M 0.13% 184
2014
Q2
$90.8M Buy
321,442
+3,032
+1% +$856K 0.11% 232
2014
Q1
$95.6M Buy
318,410
+4,713
+2% +$1.42M 0.12% 210
2013
Q4
$86.3M Buy
313,697
+2,275
+0.7% +$626K 0.1% 224
2013
Q3
$97.4M Buy
311,422
+13,718
+5% +$4.29M 0.13% 188
2013
Q2
$66.9M Buy
+297,704
New +$66.9M 0.09% 252